Risk assessment for multiple myeloma: preliminary results of the brazilian myeloma study group

The Durie/Salmon staging system continues to be used worldwide in patients with multiple myeloma. However, in recent years, new systems have been proposed. The International Myeloma Working Group performed a retrospective study with 11,179 patients and proposed an "International Staging System&...

Full description

Saved in:
Bibliographic Details
Published in:Revista brasileira de hematologia e hemoterapia 2008-06, Vol.30 (suppl 2), p.6-9
Main Authors: Maiolino, Angelo, Hungria, Vania, Oliveira, Gislaine D., Miranda, Eliana C. M., Magalhães, Roberto, Mercante, Daniel, Rego, Eduardo M., Oliveira, Luciana, Chiattone, Carlos S., Nucci, Marcio, Lorand-Metze, Irene, Zalcberg, Ilana, Souza, Cármino A. de
Format: Article
Language:English
Subjects:
HEMATOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Durie/Salmon staging system continues to be used worldwide in patients with multiple myeloma. However, in recent years, new systems have been proposed. The International Myeloma Working Group performed a retrospective study with 11,179 patients and proposed an "International Staging System" utilizing serum levels of â2 microglobulin and albumin. In addition, current research has focused on the usefulness of cytogenetic and molecular data as prognostic factors. These data suggest that these parameters are powerful discriminators of a poor prognostic group of myeloma patients. Indeed, these prognostic indexes have been utilized in clinical trials, with interesting and encouraging results.
ISSN:1516-8484
1806-0870
1516-8484
DOI:10.1590/S1516-84842008000800004